---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Enzyme

🌎 enzyme.finance

Enzyme Finance is a digital asset management platform that aims to safeguard operations and streamline the management of digital assets for institutional investors, asset managers, digital-natives, and DAOs. Using smart-contract automation, Enzyme lowers total expense ratios by more than 90%.

---

Updates as of Sep 11, 2024

• Enzyme's strategy is now live on Arbitrum, offering competitive yields on dlcBTC and wBTC.
• Enzyme now offers yield earning on Arbitrum for dlcBTC and wBTC deposits while maintaining a delta neutral position.
• Enzyme partners with dlcBTC to offer delta neutral yield on BTC via Arbitrum.
• Enzyme joined Arbitrum to offer DeFi automation tools for building vaults.
• Enzyme announced that Arc Revolution will launch the Leo vault to trade major cryptocurrencies.

• Enzyme has partnered with Myso Finance, as announced by Myso Finance ambassador Yuli Kay on September 5.
• Enzyme has committed to acquiring a majority stake in MYSO Finance to expand on-chain structured products.
• Enzyme's Assets Under Management decreased from $136,891,765.35 to $135,026,161.20.
• Nexus Mutual DAO is using Enzyme to manage their pool collateral.

---

Did you find it useful?

If you liked this report, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.